Startseite The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
Artikel Open Access

The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O

  • Liansu Pang ORCID logo und Xiaojun Shao EMAIL logo
Veröffentlicht/Copyright: 24. Januar 2023

Abstract

C17H21ClN2O, orthorhombic, Pna21 (no. 33), a = 9.2750(10) Å, b = 12.8640(17) Å, c = 13.483(2) Å, β = 90°, V = 1608.8(4) Å3, Z = 4, R gt(F) = 0.0681, wR ref(F 2) = 0.1361, T = 293 K.

CCDC no.: 2234104

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.18 × 0.16 × 0.13 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.24 mm−1
Diffractometer, scan mode: φ and ω
θ max, completeness: 29.1°, >99%
N(hkl)measured, N(hkl)unique, R int: 4764, 2883, 0.033
Criterion for I obs, N(hkl)gt: I obs > 2 σ(I obs), 1586
N(param)refined: 190
Programs: CrysAlisPRO [1], SHELX [2, 3], Olex2 [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.5550 (8) 0.5704 (6) 0.6735 (5) 0.074 (2)
C2 0.6058 (7) 0.4717 (6) 0.6901 (5) 0.073 (2)
H2 0.681302 0.460949 0.734323 0.087*
C3 0.5447 (6) 0.3887 (5) 0.6411 (4) 0.0563 (16)
H3 0.578796 0.321825 0.653013 0.068*
C4 0.4329 (5) 0.4036 (4) 0.5742 (4) 0.0451 (14)
C5 0.3855 (6) 0.5034 (4) 0.5584 (5) 0.0544 (15)
H5 0.312336 0.515252 0.512593 0.065*
C6 0.4437 (7) 0.5859 (5) 0.6087 (5) 0.070 (2)
H6 0.407469 0.652513 0.598776 0.084*
C7 0.4277 (5) 0.2308 (4) 0.4942 (4) 0.0494 (14)
C8 0.3687 (4) 0.0555 (4) 0.4228 (4) 0.0438 (12)
C9 0.4424 (6) −0.0101 (4) 0.5014 (4) 0.0575 (15)
H9A 0.381307 −0.014659 0.559641 0.069*
H9B 0.532412 0.022561 0.520828 0.069*
C10 0.4725 (7) −0.1192 (5) 0.4615 (5) 0.0680 (18)
H10 0.522624 −0.160006 0.512355 0.082*
C11 0.3270 (7) −0.1704 (5) 0.4381 (6) 0.091 (2)
H11A 0.268451 −0.173828 0.497584 0.110*
H11B 0.342069 −0.240570 0.413967 0.110*
C12 0.2500 (7) −0.1050 (5) 0.3585 (6) 0.082 (2)
H12 0.157160 −0.136849 0.341646 0.098*
C13 0.3450 (9) −0.0994 (6) 0.2668 (6) 0.099 (3)
H13A 0.296444 −0.059527 0.215647 0.119*
H13B 0.361510 −0.168934 0.241457 0.119*
C14 0.4891 (8) −0.0484 (6) 0.2914 (5) 0.079 (2)
H14 0.548755 −0.044880 0.231510 0.094*
C15 0.4633 (7) 0.0604 (5) 0.3310 (4) 0.0642 (17)
H15A 0.416632 0.102330 0.280541 0.077*
H15B 0.554760 0.092645 0.347384 0.077*
C16 0.2264 (5) 0.0046 (4) 0.3968 (5) 0.0652 (18)
H16A 0.177663 0.045545 0.346469 0.078*
H16B 0.165236 0.002476 0.455093 0.078*
C17 0.5647 (7) −0.1137 (5) 0.3694 (6) 0.078 (2)
H17A 0.581266 −0.183240 0.343873 0.094*
H17B 0.657377 −0.083088 0.385312 0.094*
Cl1 0.6316 (3) 0.67399 (19) 0.7355 (2) 0.1461 (11)
N1 0.3642 (4) 0.3206 (4) 0.5260 (4) 0.0587 (14)
H1 0.273159 0.326898 0.515494 0.070*
N2 0.3342 (4) 0.1599 (3) 0.4606 (4) 0.0563 (13)
H2A 0.244606 0.177157 0.461102 0.068*
O1 0.5605 (3) 0.2186 (3) 0.4972 (3) 0.0615 (12)

Source of materials

A mixture of 4-chlorophenyl isocyanate (153 mg, 1 mmol), amantadine (166 mg, 1.1 mmol), and dichloromethane (10 mL) was heated at 313 K under reflux for 2 h. On cooling, the mixture was stirred for 24 h. After dichloromethane volatilization, the crude product of the title compound was obtained. Subsequently, a 50 mg product sample was dissolved in 10 mL EtOH/CHCl3 (1:1) solvent. Crystals were obtained after four days from solvent at room temperature.

Experimental details

The structure was solved with the ShelXT [2] structure solution program and refined with the ShelXL [3] refinement package [4]. All hydrogen atoms were placed in calculated positions with fixed isotropic thermal parameters.

Comment

Many 1-adamantyl-3-phenyl ureas, such as 1-(adamantan-2-yl)-3-(2,3,4-trifluorophenyl)urea, 1-(adamantan-2-yl)-3-(4-cyanoph-enyl)urea, and methyl 4-(3-(1-adamantyl)ureido)-2-hydroxy-benzoate have been identified as potent anti-tuberculosis activity compounds [5, 6]. The detailed crystal structure analysis of similar compounds is helpful to the development of innovative drugs for tuberculosis. There are many phenyl urea crystal structures have been reported [7], [8], [9], [10], [11], [12]. A series of interesting solid-state systems and functional solution aggregates were designed via hydrogen bonds between urea groups. However, only a few 1-(1-adamantyl)-3-substituted urea derivatives have been reported [13].

The same space group and close cell paraments of the compound in this contribution and its isostructural bromo derivative must be mentioned [13]. The molecules formed zigzag polymeric chains along the (a) axis via two classical intermolecular hydrogen bonds, N1–H1···O1 with an H···A distance of 2.072(3) Å, and an angle of 158.1(4)°, and N2–H2A···O1 with an H···A distance of 2.225(4) Å, and an angle of 154.0(3)°. These two hydrogen bonds are more symmetrical than the corresponding hydrogen bonds with distances of 2.39(3) and 2.12(4) Å and the angles 156(3)° and 161(3)° in its isostructural bromo compound. The crystal configuration of molecules combining via hydrogen bonds was similar to the reported urea compound crystals [7], [8], [9], [10], [11], [12]. In addition, the molecule conformation, including bond lengths, angles, and torsion angles of the adamantane ring system and the 4-chlorophenyl group, are consistent with previously published structures [14, 15].


Corresponding author: Xiaojun Shao, Hainan Hospital of PLA General Hospital, Sanya, 572000, China, E-mail:

  1. Author contributions: All the authors have accepted respon-sibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku, O. D. CrysAlisPRO; Rigaku Oxford Diffraction Ltd: Yarnton, Oxfordshire, England, 2017.Suche in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

5. Brown, J. R., North, E. J., Hurdle, J. G., Morisseau, C., Scarborough, J. S., Sun, D., Korduláková, J., Scherman, M. S., Jones, V., Grzegorzewicz, A. The structure-activity relationship of urea derivatives as anti-tuberculosis agents. Bioorg. Med. Chem. 2011, 19, 5585–5595; https://doi.org/10.1016/j.bmc.2011.07.034.Suche in Google Scholar PubMed PubMed Central

6. North, E. J., Scherman, M. S., Bruhn, D. F., Scarborough, J. S., Maddox, M. M., Jones, V., Grzegorzewicz, A., Yang, L., Hess, T., Morisseau, C. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties. Bioorg. Med. Chem. 2013, 21, 2587–2599; https://doi.org/10.1016/j.bmc.2013.02.028.Suche in Google Scholar PubMed PubMed Central

7. Ali, H., Halim, S. N. A., Khamis, N. A., Yusof, M. S., Yamin, B. M. N-(p–Methoxybenzoyl)-N′-(o-methoxyphenyl)thiourea. Acta Crystallogr. 2004, E60, o1497–o1498; https://doi.org/10.1107/s1600536804018823.Suche in Google Scholar

8. Xu, M., Jupp, A. R., Ong, M. S. E., Burton, K. I., Chitnis, S. S., Stephan, D. W. Synthesis of urea derivatives from CO2 and silylamines. Angew. Chem. Int. Ed. 2019, 58, 5707–5711; https://doi.org/10.1002/anie.201900058.Suche in Google Scholar PubMed

9. Choi, H., Shim, Y. S., Lee, S. C., Kang, S. K., Sung, C. K. 1-(2–Hydroxy-2-phenylethyl)-3-(4-methoxyphenyl)urea. Acta Crystallogr. 2011, E67, o2632; https://doi.org/10.1107/s1600536811036464.Suche in Google Scholar

10. Capacci-Daniel, C. A., Mohammadi, C., Urbelis, J. H., Heyrana, K., Khatri, N. M., Solomos, M. A., Swift, J. A. Structural diversity in 1,3-bis(m-cyanophenyl)urea. Cryst. Growth Des. 2015, 15, 2373–2379; https://doi.org/10.1021/acs.cgd.5b00168.Suche in Google Scholar

11. Koshti, V. S., Thorat, S. H., Gote, R. P., Chikkali, S. H., Gonnade, R. G. The impact of modular substitution on crystal packing: the tale of two ureas. CrystEngComm 2016, 18, 7078–7094; https://doi.org/10.1039/c6ce01324d.Suche in Google Scholar

12. Capacci-Daniel, C. A., Bertke, J. A., Dehghan, S., Hiremath-Darji, R., Swift, J. A. Concomitant polymorphs of 1,3-bis(3-fluorophenyl)urea. Acta Crystallogr. 2016, C72, 692–696; https://doi.org/10.1107/s2053229616013565.Suche in Google Scholar

13. Al-Omary, F. A. M., Al-Rasheed, L. S., Ghabbour, H. A., El-Emam, A. A. Crystal structure of 3-(adamantan-1-yl)-1-(4-bromophenyl)urea, C17H21BrN2O. Z. Kristallogr. N. Cryst. Struct. 2017, 232, 37–39; https://doi.org/10.1515/ncrs-2016-0118.Suche in Google Scholar

14. Mohamed, S. K., Akkurt, M., Singh, K., Marzouk, A. A., Abdelhamid, A. A. 2-(4–Chlorophenyl)-1-pentyl-4,5-diphenyl-1H-imidazole. Acta Crystallogr. 2013, E69, o1243; https://doi.org/10.1107/s1600536813018229.Suche in Google Scholar

15. Koneczny, M., Erol, A. B., Mauduit, M., Eisen, M. S., Tamm, M. Titanium complexes with unsymmetrically substituted imidazolin-2-iminato ligands. Dalton Trans. 2022, 51, 11448–11456; https://doi.org/10.1039/d2dt01740g.Suche in Google Scholar PubMed

Received: 2022-11-20
Accepted: 2023-01-03
Published Online: 2023-01-24
Published in Print: 2023-04-25

© 2022 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
  4. The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
  5. Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
  6. Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
  7. Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
  8. The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
  9. The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
  10. Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
  11. The crystal structure of strictic acid, C20H26O3
  12. Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
  13. The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
  14. The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
  15. Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
  16. Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
  17. Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
  18. Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
  19. Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
  20. Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
  22. Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
  23. Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
  24. Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
  25. Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  26. Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
  27. Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
  28. Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
  29. Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
  30. Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
  31. Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
  32. The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
  33. The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
  34. Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
  35. Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
  36. Crystal structure of niobium trigallide, NbGa3
  37. Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
  38. Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
  39. The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
  40. The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
  41. Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
  42. Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
  43. The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
  44. Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
  45. Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
  46. Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
  47. Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
  48. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
  49. The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
  50. Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
  51. Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
  52. Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
  53. Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
  54. Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
  55. The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
  56. Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
  57. The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
  58. Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
  59. Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
  60. Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
  61. Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
  62. Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
  63. Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
  64. Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
  65. Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
  66. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
  67. The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
  68. The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
  69. Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
  70. Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
  71. One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
  72. The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
  73. Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
  74. The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
  75. The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
  76. The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
  77. Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
  78. Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0537/html
Button zum nach oben scrollen